Trial intelligence / Profile preview

Dexmedetomidine infusion during cardiac surgery for prevention of postoperative delirium

IRCT20180724040575N4Phase 3Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of dexmedetomidine in delirium (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Postoperative delirium. Started Apr 2019; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

delirium

Beyond the preview

Go deeper on IRCT20180724040575N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20180724040575N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call